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Several pathogenic human herpesviruses have recently been shown to express virally encoded microRNAs in infected cells. Although the
function of these microRNAs is largely unknown, they are hypothesized to play a role in mediating viral replication by downregulating cellular
mRNAs encoding antiviral factors. Here, we report the cloning and analysis of microRNAs encoded by Rhesus Monkey Rhadinovirus (RRV), an
animal virus model for the pathogenic human γ-herpesvirus Kaposi's Sarcoma-Associated Herpesvirus (KSHV). RRV expresses several
microRNAs that are encoded in the same genomic location as the previously reported KSHV microRNAs, yet these microRNAs are unrelated in
primary sequence. These data set the stage for the mutational ablation and phenotypic analysis of RRV mutants lacking one or more viral
microRNAs.
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MicroRNAs (miRNAs) are a ubiquitous class of∼22 nt long
regulatory RNAs that post-transcriptionally regulate the
expression of numerous eukaryotic genes (Bartel, 2004). In
addition to being encoded by the genomes of all known
metazoan eukaryotes, miRNAs have also been identified in
several DNA viruses, particularly herpesviruses (Cullen, 2006).
While some viral miRNAs appear to regulate the expression of
viral genes transcribed from the opposite genome strand (Pfeffer
et al., 2004; Sullivan et al., 2005), the majority are believed to
downregulate cellular genes that act to reduce viral replication,
including genes involved in mediating innate or adaptive
immune responses (Gupta et al., 2006). Examples of herpes-
viruses that encode miRNAs include Kaposi's Sarcoma-
Associated Herpesvirus (KSHV), which encodes 12 viral
miRNAs (Cai et al., 2005; Pfeffer et al., 2005; Samols et al.,
2005; Grundhoff et al., 2006), and Epstein-Barr Virus (EBV),
which expresses at least 23 miRNAs in infected cells (Pfeffer et⁎ Corresponding author. Fax: +1 919 681 8979.
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rhesus lymphocryptovirus (rLCV), a non-human relative of
EBV that infects rhesus macaques, has so far identified 16
distinct miRNAs, 8 of which are evolutionarily conserved in
EBV (Cai et al., 2006). To extend these data, we have cloned
and analyzed the miRNAs expressed by Rhesus Monkey
Rhadinovirus (RRV), a simian rhadinovirus, closely related to
human KSHV, that is both genetically tractable and readily
grown in culture (Alexander et al., 2000; DeWire et al., 2003;
Bilello et al., 2006; Estep et al., 2007; O'Connor and Kedes,
2007). Here, we report the identification of primary miRNA
stem–loop precursors in RRV that give rise to 11 distinct viral
miRNAs. While the genomic localization of the viral miRNAs
is conserved between RRV and KSHV, none of the RRV
miRNAs is similar in sequence to the previously reported
KSHV miRNAs.
Results
KSHVestablishes latent infections inmany adherent cell lines,
including telomerase-immortalized microvascular endothelial
cells and transformed dermal microvascular cells (Blackbourn et
22 Rapid Communicational., 2000; Bechtel et al., 2003). To establish an analogous
endothelial cell culture system appropriate for studying RRV,
rhesus monkey vascular endothelial cell cultures (MVECs) were
infected with a previously described recombinant strain of RRV
(Bilello et al., 2006) that expresses green fluorescent protein
(GFP) and then monitored for GFP expression over time. While
GFP expression was apparent by day 4 post-infection, the
percentage of GFP positive cells was low (approximately
2–4%). The RRV-infected MVEC cultures were passed when
confluent and the percentage of GFP-positive cells progressively
increased over time to approximately 90% at day 24 post-
infection. While mild cytopathology was observed, the appear-
ance of the infected MVEC cultures was not markedly different
from that seen in uninfected cultures passed in parallel. The titer
of RRV-GFP in the MVEC culture supernatant at days 20 and 24
post-infection was approximately 104 pfu/ml, approximately 1%
of what is observed in the supernatant of rhesus fibroblast
cultures lytically infected with RRV-GFP (Bilello et al., 2006).
The infection of the MVEC cells therefore appeared to be
predominantly latent, although some of theMVECs were clearly
producing infectious RRV.
At day 24 post-infection, total RNA was isolated from the
RRV-infected MVECs and used as a source for the isolation and
reverse transcription of small RNAs of 18 nt to 26 nt in size, as
previously described (Cai et al., 2005). The resultant cDNAs
were concatamerized, cloned and sequenced. This cDNA
cloning approach is predicted to clone all cellular and viral
miRNAs as well as fragments of cellular mRNAs and non-
coding RNAs that fall into this size range. The 19 to 24 bp long
cDNA clones that were obtained were identified by computa-
tional analysis by comparison to the RRV genome sequence as
well as to databases covering cellular miRNAs, noncoding
RNAs and mRNAs. However, as the cells analyzed were of
rhesus macaque origin, not all cloned sequences obtained could
be clearly annotated. Nevertheless, this approach will identify
all cloned cDNAs that represent RRV miRNAs.
A complete listing of all the cellular miRNAs cDNA cloned
from the MVECs is provided in Supplementary Table 1 while
the genomic origin of all the cDNA clones obtained is indicated
in Supplementary Fig. 1. Analysis of the 684 19–24 bp longTable 1
Identity and genomic location of RRV miRNAs recovered from latently RRV-infect












This table shows the sequence, length, cloning frequency and genomic position of
26–95 isolate of RRV (accession number AF210726). Terminal variation in the le
nucleotide. Where two miRNAs appear to derive from a single stem–loop precursorcDNAs obtained from the RRV-infected MVECs revealed 185
cellular miRNAs of which let-7 (82 cDNA clones), miR-125b-2
(26 clones), miR-221 (24 clones) and miR-100 (14 clones) were
the most prevalent. We also obtained 138 cDNA clones of
mRNA origin, 131 cDNA clones of rRNA origin and 20 cDNA
clones of tRNA origin. A total of 102 rhesus cDNA clones were
not identified by this analysis but were clearly not of RRV
origin. The remaining 108 cDNA clones were all derived from
the infecting RRV virus and represent 11 different RRV-derived
miRNAs (Table 1). As expected, the viral miRNAs obtained
ranged from 19 to 24 nt in length, with the majority 21 to 23 nt
long.
MiRNAs are initially transcribed as part of one arm of an
RNA hairpin that in turn forms part of a longer capped,
polyadenylated primary miRNA transcript (Bartel, 2004).
Computer analysis of the RRV sequences flanking the cloned
RRV miRNAs revealed that all but one of these candidate RRV
miRNAs could indeed be folded into the imperfect RNA
hairpins that are characteristic of primary miRNA transcripts
(Fig. 1). However, one candidate RRV miRNA, i.e. miR-rR1-3,
was not readily folded into the expected RNA hairpin structure.
This RRV miRNA will be further discussed below.
Of the 11 RRV miRNAs obtained, 8 derive from 4 stem–
loop precursors and therefore represent either two miRNAs of
different function or a functional miRNA and a “passenger”, i.e.
a non-functional, strand. In either case, these 2 short RNAs
should anneal to form an imperfect stem in the primary
precursor, leaving ∼2 nt 3′ overhangs at each end (Bartel,
2004). As can be seen in Fig. 1, this was generally the case.
Moreover, the structure of these RRV primary miRNA
precursors, consisting of the central miRNA duplex, a basal
∼10 bp stem extension and a large, ≥10 nt terminal loop, is
consistent with earlier work that has defined structural features
present in primary miRNA hairpins that are recognized by the
cellular RNA processing enzyme Drosha and its co-factor
DGCR8 (Zeng et al., 2005).
To further confirm the validity of the RRV miRNAs listed in
Table 1, and to see whether both strands of miR-rR1-1, miR-
rR1-4, miR-rR1-6 and miR-rR1-7 could indeed be detected in
RRV-infected cells, we performed primer extension analyses toed MVECs












the RRV miRNAs cloned in this analysis. Coordinates are given relative to the
ngth of miRNA cDNA clones is indicated by parentheses around the variable
RNA, the more 5′ miRNA is indicated by the suffix-5p and the more 3′ by −3p.
Fig. 1. Predicted RNA folding of the primary miRNA stem–loop structures that give rise to 10 of the 11 RRV miRNAs listed in Table 1. Cloned RRV miRNAs are
indicated in red.
23Rapid Communicationdetect all 11 of the viral miRNAs listed in Table 1. The primers
used were designed to be 5 or 6 nucleotides shorter, at the 3′
end, than the full-length viral miRNA sequences listed in Table
1. The RNA preparation used was derived from a human cell
line, 293, that had been infected at high multiplicity with the
RRV-GFP virus. Infection of 293 cells with RRV results in a
mixture of cells that become lytically and latently infected
(DeWire and Damania, 2005). This experiment allowed us to
analyze RRV miRNA expression in a second, distinct RRV-
infected cell line.
As shown in Fig. 2, this primer extension analysis detected
all 11 of the RRV miRNAs in infected 293 cells that had been
previously cloned from infected MVEC cells, although some
signals, e.g. for miR-rR1-1-3p, were quite faint. This latter
result is consistent with the fact that miR-rR1-1-3p was onlyFig. 2. Detection of RRV miRNAs using primer extension analysis. The RNA
samples analyzed were derived from control 293 cells or from 293 cells that
were infected with RRV at high multiplicity and that were beginning to enter
lytic replication. The primers used were all designed to be 5 or 6 nt shorter, at the
3′ end, than the mature RRV miRNAs listed in Table 1. In the case of miR-rR1-
7-5p, we detected two primer extension products, differing by 1 nt in length, as
predicted in Table 1. All other miRNAs gave rise to a single extension product,
with the possible exception of miR-rR1-4.cloned once from infected MVEC cells while the complimen-
tary miR-rR1-1-5p miRNAwas cloned 27 times (Table 1) and is
also more readily detected (Fig. 2). This suggests that miR-rR1-
1-5p is the active viral miRNAwhile miR-rR1-1-3p is likely the
passenger strand. For other RRVmiRNAs, e.g. miR-rR1-4, both
the 5p and 3p strands were cloned multiple times (Table 1) and
gave rise to robust primer extension signals (Fig. 2), so it is
currently unclear whether only the more highly expressed miR-
rR1-4-5p is physiologically relevant or whether both strands are
active miRNAs. Importantly, the miR-rR1-3 miRNA, which
was not readily folded into the expected primary miRNA
hairpin structure, was also readily detected in RRV-infected 293
cells (Fig. 2). We therefore conclude that this candidate miRNA
is, in fact, an authentic RRV miRNA. It is therefore likely that it
does indeed form part of an RNA hairpin in the primary miRNA
precursor even though we have not yet been able to deduce a
convincing hairpin structure.
Consistent with the data shown in Table 1, miR-rR1-7-5p
was found to give rise to 2 primer extension products. However,
miR-rR1-2, which like miR-rR1-7-5p also gave rise to 2 cDNA
clones differing by 1 nucleotide at the 5′ end (Table 1), only
gave a single primer extension product (Fig. 2). This may imply
that only the longer, 21 nt version of miR-rR1-2 is actually
expressed in vivo and that the single, 20 nt cDNA sequence
obtained had lost one 5′ nucleotide during RNA isolation or
cDNA synthesis. These data also suggested that miR-rR1-5,
which was cloned only once from RRV-infected MVECs yet
was readily detected in RRV-infected 293 cells, also exists in
two forms differing by 1 nt at the 5′ end. In any event, these
primer extension data clearly validate the existence of all of the
RRV miRNAs listed in Table 1.
An interesting question is whether these RRV miRNAs are
induced during lytic RRV replication. To address this question,
we took advantage of the previous finding that RRV can be
maintained in a latent state in infected 293 cells by treatment
with the antiviral drug ganciclovir but enters lytic replication
when cultured in the absence of this inhibitor. We therefore
prepared total RNA from uninfected 293 cells, 293 cells
infected with RRVand maintained in the presence of ganciclovir
and finally 293 cells infected with RRV and maintained in the
Fig. 3. RRV miRNA expression is enhanced upon entry into the lytic phase. (A)
RT-PCR analysis of the expression of a latent RRV mRNA (ORF71), a lytic
RRV mRNA (ORF50/RTA) and a control cellular mRNA (GAPDH) using total
RNA derived from uninfected 293 cells, 293 cells maintained in the latent phase
of the RRV replication cycle by treatment with ganciclovir, or lytically RRV-
infected 293 cells. Reactions were controlled for contaminating cellular DNA by
performing the PCR amplification without first performing a reverse transcrip-
tion (RT) step. (B) This primer extension analysis was performed as described in
Fig. 2 using the RNA preparations described in panel A. The cellular miR-16
miRNA served as a loading control.
Fig. 4. Schematic representation of the genomic localization of the miRNAs encode
RRV and KSHV in the latency associated region, as well as the K12/Kaposin gene
infection while ORF68 and ORF69 are lytic genes (indicated in grey). The transcrip
indicated.
24 Rapid Communicationabsence of drug. To confirm the state of the viral infection, we
performed RT-PCR analysis using primers specific for the RRV
ORF71 mRNA, which should be expressed during both latent
and lytic infection, and the RRV ORF50/RTA mRNA, which
encodes a viral protein seen exclusively in lytically infected
cells. As shown in Fig. 3A, the ORF71 mRNA was indeed
detected in RRV-infected 293 cells regardless of drug treatment,
while the ORF50/RTA mRNA was only detected in RRV-
infected 293 cells cultured in the absence of ganciclovir. Primer
extension analyses for three of the RRV miRNAs (miR-rR1-2,
miR-rR1-3 and miR-rR1-5) showed that all three miRNAs were
detectable in latently RRV-infected 293 cells but were strongly
activated in 293 cells undergoing lytic replication. No increase
was observed when a cellular miRNA, human miR-16, was
analyzed in parallel. We therefore conclude that RRV miRNA
expression is indeed activated during lytic virus replication.
The 12 KSHV miRNAs previously identified by ourselves
and others (Cai et al., 2005; Pfeffer et al., 2005; Grundhoff et al.,
2006) cluster into a small, primarily non-coding region within
the KSHV genome located between the ORF69 and ORF71
(also known as the V-FLIP) genes. As shown in Fig. 4, this is
also true in RRV, although RRV lacks the K12/Kaposin gene
found in KSHV. In both viruses, all the miRNAs are in the same
transcriptional orientation and, in latently KSHV-infected cells,
it has, in fact, been shown that all the KSHV miRNAs are
derived from transcripts that initiate 5′ to ORF71 and terminated by RRV and KSHV. This schematic shows the viral genes conserved between
unique to KSHV. ORF73, ORF72, ORF71 and K12 are expressed during latent
tional orientation of the viral protein coding genes and of the viral miRNAs is
25Rapid Communicationtranscription 3′ to theK12/Kaposin gene (Cai and Cullen, 2006).
While relatively little is known about the transcriptional
regulation of RRV, it is known that there are both latent and
lytic promoters located 5′ to the ORF73 gene in RRV (DeWire
and Damania, 2005) and it is therefore possible that these
promoters give rise to transcripts that are processed to yield all
the RRV miRNAs listed in Table 1 and schematically
represented in Fig. 4.
Discussion
Previous analyses of several distinct γ-herpesviruses,
including EBV, its rhesus counterpart rLCV, KSHV and the
murine γ-herpesvirus mouse herpesvirus 68, have identified
miRNAs in all of these herpesviruses (Pfeffer et al., 2004, 2005;
Cai et al., 2005, 2006; Grundhoff et al., 2006). Therefore, our
observation that RRV also encodes miRNAs is not a surprise.
There were two principal reasons why this research was
undertaken. First, in the case of the human lymphocryptovirus
EBV and its rhesus counterpart rLCV, we have previously
reported that the viral miRNAs are conserved in terms of
genomic localization and, moreover, that 8 of the 16 miRNAs
cloned from rLCV are conserved in EBV at the primary
sequence level (Cai et al., 2006). We were therefore curious as
to whether RRV, a rhadinovirus that is closely related to the
human pathogenic herpesvirus KSHV (Alexander et al., 2000),
would show a similar pattern. Second, RRV is genetically
tractable in that mutations can be introduced into the RRV
genome and their effect then analyzed in tissue culture and in
infected rhesus macaques (Bilello et al., 2006; Estep et al.,
2007; O'Connor and Kedes, 2007). Indeed, in immunocom-
promised rhesus macaques, RRV is pathogenic. This result is
reminiscent of KSHV, which is also innocuous in immuno-
competent patients but pathogenic in immunodeficient indivi-
duals, including AIDS patients.
The data reported here reveal that the miRNAs present in
KSHV and RRV are indeed all located in a single cluster in
each virus that is found at the same genomic location. In
addition, in both KSHV and RRV, all the viral miRNAs are in
the same transcriptional orientation (Fig. 4). It therefore seems
likely that the transcription and processing of the RRV
miRNAs occur via essentially the same mechanism seen in
KSHV. Specifically, in KSHV, miRNA expression is
dependent on promoters located 5′ to the viral ORF72 and
ORF73 genes and requires the read-through of a “leaky”
poly-(A) addition site located 3′ to ORF71 (Cai and Cullen,
2006). This results in long transcripts that, at least in latently
KSHV-infected cells, are processed to give rise to all 12
KSHV miRNAs (Fig. 3). In RRV, transcription is less well
understood but lytic and latent promoters located 5′ to RRV
ORF73 have been identified (DeWire and Damania, 2005)
and there is a consensus poly(A) addition site located
immediately 3′ to RRV ORF71. Whether this RRV poly(A)
addition site shares the leakiness characteristic of the
equivalent site in KSHV, thereby giving rise to a single
primary miRNA precursor for all the RRV miRNAs, remains
to be determined.One important difference between KSHV and RRV is that,
in the case of KSHV, the majority of the viral miRNAs show at
most a modest increase in expression upon entry into lytic
replication (Cai et al., 2005; Pfeffer et al., 2005). The
exceptions are miR-K10 and miR-K12, which are significantly
induced upon entry into lytic replication due to the presence of
a potent lytic promoter located immediately 5′ to the K12 ORF
(Cai and Cullen, 2006). In contrast, in the case of RRV, it
appears that the expression of all the viral miRNAs is strongly
enhanced during lytic replication (Fig. 3). This difference
likely results from the fact that RRV contains a potent lytic
promoter located immediately 5′ to the ORF73 gene (DeWire
and Damania, 2005) that is lacking in KSHV (Cai and Cullen,
2006). In contrast, the lytic promoter located 5′ to the K12
ORF of KSHV, as well as the K12 ORF itself, are both absent
in RRV (Fig. 4).
A perhaps somewhat surprising result reported here is that
we only identified 6 distinct primary miRNA stem–loops in
RRV (Fig. 2) that give rise to 10 viral miRNAs (Table 1) (an
additional RRV miRNA, miR-rR1-3, could not be assigned
to an RNA stem–loop structure but was readily detectable in
RRV-infected cells, as shown in Figs. 2 and 3). It therefore
is clearly possible that we have missed other viral miRNAs
that are expressed at a low level in RRV-infected MVEC
cells, although we did clone several “passenger” strands for
the more highly expressed viral miRNAs (Table 1).
However, even if other miRNAs are located in this region
of the RRV genome, computer analysis does not reveal the
presence of any sequences closely similar to any of the
KSHV miRNAs.
The finding that RRV has not conserved any of the miRNAs
present in KSHV, while 8 out of the 16 miRNAs expressed by
rLCVare conserved in EBV (Cai et al., 2006), likely reflects the
greater sequence divergence between the genomes of KSHV
and RRV, when compared to EBV and rLCV (Alexander et al.,
2000; Cai et al., 2006). However, despite the fact that none of
the KSHV miRNAs is conserved in RRV, it clearly remains
possible that these viral miRNAs downregulate the same host
innate or adaptive immune response pathways and possibly
even the same mRNAs. In any event, these results set the stage
for the mutational inactivation of the miRNAs present in RRV
and the future analysis of the effect of these mutations on the
replication of RRV in culture and in vivo and on the ability of
RRV to exert a pathogenic effect in immunodeficient rhesus
macaques.
Materials and methods
Maintenance of MVECs and RRV-GFP infection
Primary rhesus monkey vascular endothelial cell cultures
(MVEC21150 CGB-5), kindly provided by Dr. Jay Nelson
(Oregon Health Sciences University, Portland, OR), were
maintained in Endothelial Cell Medium 2 (EBM-2; Cambrex
BioScience, Walkersville, MD) supplemented with SingleQuots
(Cambrex). When confluent, MVECs were passed using
Accutase (Innovative Cell Technologies, San Diego, CA).
26 Rapid CommunicationOne day after passage, MVEC cultures were infected with
approximately 2×105 infectious units of RRV-GFP (Bilello
et al., 2006) and passed when cultures became confluent.
RNA extraction, cloning and analysis
At day 24 post-infection, RNAwas isolated from RRV-GFP-
infected MVEC cultures using TRIzol Reagent (Invitrogen,
Carlsbad, CA). After the addition of 0.2 vol. chloroform, the
samples were shaken vigorously for 15 s and incubated for
3 min at room temperature. Samples were then centrifuged at
12,000×g for 15 min at 4 °C and the aqueous phase transferred
to a fresh tube. Total RNA was precipitated by the addition of
0.5 vol. isopropanol, incubated at room temperature for 10 min
and centrifuged at 12,000×g for 10 min at 4 °C. The supernatant
was discarded and the RNA pellet was washed in 1 vol. 75%
ethanol followed by centrifugation at 7500×g for 5 min at room
temperature. The resultant RNA pellet was briefly dried and
dissolved in ddH2O. The isolation, cDNA cloning and sequence
analysis of the small, 18–25 nt long RNAs present within this
preparation of RRV-infected MVEC RNA was then performed
as previously described (Cai et al., 2005, 2006).
Human 293 cells were infected with the RRV-GFP virus at a
multiplicity of ∼1 pfu/cell in the presence of polybrene (5 μg/
ml). After 24 h, the supernatant medium was replaced with
fresh medium. At 72 h post-infection, all the 293 cells showed
GFP expression and ∼50% of the cells showed a cytopathic
effect indicative of lytic RRV replication. To generate latently
RRV-infected 293 cell cultures, 293 cells were infected as
above. After 1 h, the media were replaced by fresh media
containing 500 μM ganciclovir (Calbiochem). After 72 h,
essentially all the 293 cells showed GFP expression but no
cytopathic effect was evident. Total RNA was then isolated
from control, uninfected and from latently or lytically RRV-
infected 293 cells, as described above. Primer extension
analyses were performed as previously described (Cai and
Cullen, 2006) using primers that were designed to be 5 or 6 nt
shorter than human miR-16 and the mature, full-length RRV
miRNAs listed in Table 1.
RT-PCR analysis
Two micrograms of total RNA isolated from uninfected 293
cells, latently RRV-infected 293 cells or lytically RRV-infected
293 cells was treated with DNase and was then subjected to
reverse transcription using Oligo dT primers (Invitrogen/Super-
script II). The resultant cDNAs were amplified with previously
described primers specific for RRV ORF50/RTA (Dittmer et al.,
2005), RRV ORF71 (DeWire and Damania, 2005) or human
GAPDH (Cai et al., 2004). The PCR amplification was
performed for 35 cycles (ORF71) or 30 cycles (ORF50 and
GAPDH) at 94 °C for 30 s, 42 °C for 30 s and 72 °C for 30 s.
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